trending Market Intelligence /marketintelligence/en/news-insights/trending/yuliti1x7ryaulx9gva0ga2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

PAVmed seeks US FDA approval for drug delivery technology

Street Talk Episode 51 - Goldman Talks Libor Transition, Recent SOFR Volatility

#ChangePays: Although Still Underrepresented, Women in the C-Suite are Driving Profitability

Cable Nets For Kids Enjoy Wide Carriage On Skinny Bundles


Power Forecast Briefing: Fleet Transformation, Under-Powered Markets, and Green Energy in 2018

PAVmed seeks US FDA approval for drug delivery technology

PAVmed Inc. filed a 510(k) premarket notification submission with the U.S. FDA for its PortIO Intraosseous Infusion System.

The system consists of an implantable vascular access device and insertion kit that allows direct access to the bone marrow for the delivery of medications.